Fig. 1From: Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 casesA schematic flow of the reader study (AI: artificial intelligence, ER: estrogen receptor, HER2: human epidermal growth factor receptor 2, PR: progesterone receptor)Back to article page